Vivos Therapeutics Inc (VVOS) — Defensive Interval Ratio
Vivos Therapeutics Inc (VVOS) has a Defensive Interval Ratio of 36 days as of March 2026. Defensive assets of $1.77 Million (cash $-, short-term investments $-, receivables $1.77 Million) cover 36 days of daily cash needs of $49.14K/day. See VVOS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Vivos Therapeutics Inc Defensive Interval Ratio (2018–2025)
This chart shows how Vivos Therapeutics Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 36 days, meaning defensive assets of $1.77 Million can fund 36 days of operations without new revenue. See debt-free asset ratio of Vivos Therapeutics Inc to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Vivos Therapeutics Inc (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Vivos Therapeutics Inc from 2018 to 2025, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Vivos Therapeutics Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 32 days | $1.58 Million | $49.52K/day | $- | $- | ▲ +0 days |
| 2024 | 32 days | $430.00K | $13.64K/day | $- | $- | ▲ +21 days |
| 2023 | 10 days | $202.00K | $19.97K/day | $- | $- | ▼ -14 days |
| 2022 | 24 days | $457.00K | $18.67K/day | $- | $- | ▼ -59 days |
| 2021 | 84 days | $1.72 Million | $20.57K/day | $- | $- | ▲ +13 days |
| 2020 | 71 days | $1.52 Million | $21.43K/day | $- | $- | ▲ +32 days |
| 2019 | 38 days | $955.99K | $24.91K/day | $- | $- | ▼ -62 days |
| 2018 | 101 days | $595.19K | $5.91K/day | $- | $- | — |